{"id":"NCT00713193","sponsor":"Ohio State University","briefTitle":"Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)","officialTitle":"A Multi-Center, Randomized Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in the Initial Therapy of Thrombotic Thrombocytopenic Purpura (TTP)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11","primaryCompletion":"2017-09-20","completion":"2017-09-20","firstPosted":"2008-07-11","resultsPosted":"2023-04-28","lastUpdate":"2023-05-03"},"enrollment":26,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Thrombotic Thrombocytopenic Purpura"],"interventions":[{"type":"DRUG","name":"Cyclosporine","otherNames":["Neoral"]},{"type":"DRUG","name":"Prednisone","otherNames":["Steroid arm"]}],"arms":[{"label":"Cyclosporine and Plasma Exchange Arm","type":"EXPERIMENTAL"},{"label":"Prednisone and Plasma Exchange Arm","type":"ACTIVE_COMPARATOR"}],"summary":"This research involves the use of immune base therapy as an adjunct to plasma exchange, the present standard of care for thrombotic thrombocytopenic purpura (TTP). Funding source -FDA OOPD","primaryOutcome":{"measure":"Number of Participants With Exacerbations in the CSA/PEX Arm Compared to the Steroids/PEX Arm","timeFrame":"From the start of treatment until 30 days after discharge from the last PEX procedure","effectByArm":[{"arm":"CSA Arm","deltaMin":3,"sd":null},{"arm":"Prednisone Arm","deltaMin":1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["29296854"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":[]}}